GlaxoSmithKline (GSK)

Add to Watchlists Create an Alert
47.10 -0.20  -0.41% NYSE Sep 17, 5:00PM BATS Real time Currency in USD

GlaxoSmithKline Enterprise Value:

139.40B for None

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Enterprise Value Chart

Export Data
Save Image

GlaxoSmithKline Historical Enterprise Value Data

View and export this data going back to 1986. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Sept. 16, 2014 139.40B
Sept. 15, 2014 138.63B
Sept. 12, 2014 138.82B
Sept. 11, 2014 138.51B
Sept. 10, 2014 139.35B
Sept. 9, 2014 137.84B
Sept. 8, 2014 138.15B
Sept. 5, 2014 140.89B
Sept. 4, 2014 141.54B
Sept. 3, 2014 142.57B
Sept. 2, 2014 141.78B
Aug. 29, 2014 143.72B
Aug. 28, 2014 143.17B
Aug. 26, 2014 141.71B
Aug. 25, 2014 141.39B
Aug. 22, 2014 140.31B
Aug. 21, 2014 140.36B
Aug. 20, 2014 140.62B
Aug. 19, 2014 139.52B
Aug. 18, 2014 139.78B
Aug. 15, 2014 138.37B
Aug. 14, 2014 138.73B
Aug. 13, 2014 137.67B
Aug. 12, 2014 137.74B
Aug. 11, 2014 137.69B
   
Aug. 8, 2014 137.67B
Aug. 7, 2014 137.12B
Aug. 6, 2014 140.38B
Aug. 5, 2014 142.71B
Aug. 4, 2014 142.35B
Aug. 1, 2014 141.15B
July 31, 2014 141.97B
July 30, 2014 142.21B
July 29, 2014 141.15B
July 28, 2014 141.56B
July 25, 2014 142.52B
July 24, 2014 146.08B
July 23, 2014 145.98B
July 22, 2014 153.62B
July 21, 2014 154.03B
July 18, 2014 154.82B
July 17, 2014 153.28B
July 16, 2014 153.84B
July 15, 2014 153.86B
July 14, 2014 154.48B
July 11, 2014 154.80B
July 10, 2014 156.45B
July 9, 2014 155.18B
July 8, 2014 153.96B
July 7, 2014 155.76B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for
Advertisement

GSK Enterprise Value Benchmarks

Companies
AstraZeneca 97.31B
Pfizer 194.67B
Novartis 242.21B

GSK Enterprise Value Range, Past 5 Years

Minimum 98.62B May 26 2010
Maximum 160.95B Apr 29 2014
Average 131.51B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.